| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | 0.071 | 0.3 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.047 | 0.3 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.4 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |